# Trade Mark Journal No.2025/031 1 August 2025

## WO0000001865351 (44)

Office of origin: United States of America

Date of International Registration:5 June 2025
Date of designation in the UK: 5 June 2025

International priority date claimed: 9 December 2024 (United States of America) (98891953)

Class 44
  Providing diagnostic and medical information relating to ophthalmic diseases; providing diagnostic and medical information relating to demodex blepharitis; providing diagnostic and medical information relating to ocular demodex.

Tarsus Pharmaceuticals, Inc.

Representative: Knobbe, Martens, Olson & Bear, LLP, 2040 Main St., 14th Floor, Irvine CA 92614, UNITED STATES OF AMERICA